UPDATED Aug 17, 2025
Explore the French (CAC) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALVAL | €0.90 | 1.1% | -39.5% | €14.3m | €3.00 | PS81.2x | E42.7% | n/a | ||
ALNFL | €1.44 | 0.8% | -30.6% | €18.2m | €3.90 | PS396696.3x | n/a | n/a | ||
ALINT | €0.32 | 3.2% | -50.8% | €2.1m | n/a | PB1.2x | n/a | n/a | ||
ALBPS | €0.18 | 1.4% | -73.0% | €4.2m | n/a | PE-0.4x | n/a | n/a | ||
ALVIO | €0.065 | 0.3% | -19.7% | €11.8m | n/a | PS6.6x | n/a | n/a | ||
EAPI | €3.10 | 0% | -27.9% | €295.2m | €3.08 | PB0.3x | E72.1% | n/a | ||
ALTAO | €0.0084 | 0% | -26.3% | €6.9m | n/a | PS11.2x | n/a | n/a | ||
ALOPM | €0.40 | 0% | -62.7% | €7.2m | €2.00 | PE1.1x | E41.5% | n/a | ||
ALPHE | €2.00 | 0% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
ALQGC | €0.072 | 0% | -5.0% | €5.0m | n/a | PS503305.9x | n/a | n/a | ||
ALPRE | €3.20 | 0% | -33.6% | €12.1m | €20.92 | PS24.5x | S52.4% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
PHXM | €0.10 | 0% | -94.5% | €1.0m | €4.90 | PB0.04x | E17.1% | n/a | ||
GNRO | €0.035 | 0% | -44.8% | €1.0m | n/a | n/a | n/a | n/a | ||
ALECR | €17,600.00 | 0% | -4.3% | €88.8m | n/a | PE12.4x | n/a | n/a | ||
ALCLS | €2.54 | 0% | 37.9% | €183.7m | €6.50 | PS3.4x | E9.3% | n/a | ||
MLINA | €3.82 | 0% | n/a | €28.7m | n/a | n/a | n/a | n/a | ||
ALNEV | €0.86 | -0.6% | -100.0% | €409.9k | n/a | PB0.02x | n/a | n/a | ||
ALPAT | €9.36 | -0.2% | -41.5% | €10.5m | n/a | PE11.2x | n/a | n/a | ||
ALCOX | €0.48 | -1.0% | 169.7% | €35.0m | €1.00 | n/a | E61.4% | n/a | ||
ALNOV | €0.47 | -3.5% | -66.2% | €33.4m | n/a | PS1.5x | n/a | n/a | ||
ABNX | €1.81 | -2.1% | 41.0% | €62.7m | €10.75 | PS13.8x | E-33.8% | n/a | ||
GNFT | €3.57 | -1.0% | -7.2% | €178.0m | €9.48 | PE118.1x | E-28.0% | n/a | ||
TNG | €1.02 | -1.4% | 2.0% | €135.0m | €2.00 | PS21.3x | E-4.9% | n/a |